Cofinimmo SA (CFMOF) Income Statement Analysis

See more : Allied Healthcare Products, Inc. (AHPI) Income Statement Analysis – Financial Results

Complete financial analysis of Cofinimmo SA (CFMOF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cofinimmo SA, a leading company in the REIT – Diversified industry within the Real Estate sector.

You may be interested

Cofinimmo SA (CFMOF)

Industry: REIT - Diversified

Sector: Real Estate

Website: https://www.cofinimmo.com

About Cofinimmo SA

Cofinimmo has been acquiring, developing and managing rental properties for over 35 years. The company has a portfolio spread across Belgium, France, the Netherlands, Germany and Spain, with a value of approximately 4.5 billion EUR. With attention to social developments, Cofinimmo has the mission of making high-quality care, living and working environments available to its partners-tenants, from which users benefit directly. "Caring, Living and Working - Together in Real Estate" is the expression of this mission. Thanks to its expertise, Cofinimmo has built up a healthcare real estate portfolio of approximately 2.6 billion EUR in Europe. As an independent company that applies the highest standards of corporate governance and sustainability, Cofinimmo offers its tenants services and manages its portfolio through a team of approximately 130 employees in Brussels, Paris, Breda and Frankfurt. Cofinimmo is listed on Euronext Brussels (BEL20) and benefits from the REIT system in Belgium (RREC), France (SIIC) and the Netherlands (FBI). Its activities are supervised by the Financial Services and Markets Authority (FSMA), the Belgian regulator.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	388.97M	366.42M	340.81M	295.21M	286.17M	262.63M	261.99M	256.73M	254.74M	257.22M	269.39M	267.76M	209.97M	216.20M	215.52M	198.88M	195.46M	0.00	0.00	0.00	132.44M	118.06M	116.70M
Cost of Revenue	102.19M	85.06M	77.96M	65.59M	75.76M	72.97M	63.30M	56.95M	54.88M	56.44M	59.64M	53.31M	47.79M	0.00	47.54M	40.03M	39.04M	-37.62M	-38.19M	-36.32M	49.71M	33.82M	3.12M
Gross Profit	286.78M	281.36M	262.85M	229.62M	210.41M	189.67M	198.70M	199.79M	199.87M	200.77M	209.76M	214.45M	162.17M	216.20M	167.97M	158.85M	156.42M	37.62M	38.19M	36.32M	82.73M	84.24M	113.59M
Gross Profit Ratio	73.73%	76.79%	77.12%	77.78%	73.53%	72.22%	75.84%	77.82%	78.46%	78.06%	77.86%	80.09%	77.24%	100.00%	77.94%	79.87%	80.03%	0.00%	0.00%	0.00%	62.46%	71.35%	97.33%
Research & Development	0.00	1.32	0.78	0.42	0.74	0.58	0.54	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	14.14M	13.80M	3.66M	2.90M	2.52M	2.03M	1.95M	1.69M	1.39M	1.37M	1.54M	1.85M	30.78M	28.41M	27.30M	25.51M	22.27M	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	266.00K	272.00K	193.00K	340.00K	204.00K	284.00K	291.00K	963.00K	755.00K	787.00K	708.00K	739.00K	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.13M	0.00	0.00	0.00
SG&A	14.41M	13.80M	3.86M	3.24M	2.72M	2.31M	2.24M	2.65M	2.15M	2.16M	2.25M	2.59M	30.78M	28.41M	27.30M	25.51M	22.27M	0.00	0.00	-1.13M	0.00	0.00	0.00
Other Expenses	205.87M	10.49M	32.34M	27.82M	17.54M	18.24M	27.32M	27.04M	24.37M	22.65M	24.63M	25.73M	20.18M	-13.76M	-12.30M	20.80M	-59.21M	0.00	0.00	0.00	-23.64M	-8.68M	21.57M
Operating Expenses	220.28M	24.29M	36.20M	31.06M	20.26M	20.56M	29.57M	29.70M	26.51M	24.81M	26.87M	28.32M	50.96M	52.24M	44.68M	46.31M	-36.94M	0.00	0.00	-1.13M	-23.64M	-8.68M	21.57M
Cost & Expenses	322.47M	109.35M	114.16M	96.65M	96.02M	93.52M	92.87M	86.64M	81.39M	81.25M	86.51M	81.63M	98.75M	52.24M	92.22M	86.34M	2.10M	-37.62M	-38.19M	-37.45M	26.08M	25.15M	24.68M
Interest Income	9.20M	11.50M	12.12M	7.38M	6.39M	5.62M	5.59M	5.21M	5.74M	5.58M	5.37M	5.47M	6.08M	6.04M	20.87M	29.55M	87.33M	58.86M	0.00	0.00	37.63M	38.87M	39.48M
Interest Expense	75.88M	33.35M	20.66M	14.70M	17.39M	17.96M	19.41M	22.38M	27.84M	36.21M	66.32M	30.59M	62.46M	63.28M	82.12M	89.29M	71.95M	8.28M	0.00	0.00	9.68M	10.94M	20.94M
Depreciation & Amortization	2.55M	142.45M	138.59M	116.44M	112.18M	109.88M	117.70M	115.15M	440.00K	460.00K	615.00K	706.00K	41.96M	-8.81M	1.67M	861.00K	144.00K	1.04M	488.00K	479.00K	762.00K	323.00K	659.00K
EBITDA	30.44M	437.25M	248.99M	155.51M	142.23M	153.37M	173.98M	177.14M	164.31M	15.36M	143.69M	164.32M	153.18M	155.15M	122.04M	94.57M	193.51M	38.66M	98.70M	75.34M	71.52M	68.30M	101.80M
EBITDA Ratio	7.83%	95.63%	77.66%	58.96%	92.55%	71.35%	66.40%	69.00%	64.50%	65.38%	53.34%	73.55%	72.95%	71.76%	56.63%	47.55%	99.00%	0.00%	0.00%	0.00%	54.00%	57.85%	87.23%
Operating Income	66.50M	299.55M	248.88M	168.18M	256.54M	177.95M	173.43M	176.72M	163.87M	138.54M	143.08M	191.01M	111.22M	163.96M	120.37M	93.71M	193.36M	37.62M	38.19M	37.45M	70.76M	67.97M	101.14M
Operating Income Ratio	17.10%	81.75%	73.03%	56.97%	89.65%	67.76%	66.20%	68.83%	64.33%	53.86%	53.11%	71.34%	52.97%	75.84%	55.85%	47.12%	98.93%	0.00%	0.00%	0.00%	53.43%	57.57%	86.66%
Total Other Income/Expenses	-113.63M	193.21M	24.31M	-42.33M	-40.30M	-24.02M	-22.08M	-62.93M	-60.92M	-186.27M	-107.58M	-78.46M	-20.50M	-72.09M	-85.05M	-108.12M	-38.71M	-25.45M	0.00	0.00	-45.28M	-35.88M	-11.82M
Income Before Tax	-47.13M	494.05M	275.49M	125.86M	216.24M	153.93M	145.85M	106.96M	112.41M	-47.73M	63.43M	107.56M	90.72M	91.87M	38.25M	4.42M	154.65M	0.00	0.00	0.00	61.08M	57.03M	80.20M
Income Before Tax Ratio	-12.12%	134.83%	80.83%	42.63%	75.56%	58.61%	55.67%	41.66%	44.13%	-18.55%	23.54%	40.17%	43.21%	42.49%	17.75%	2.22%	79.12%	0.00%	0.00%	0.00%	46.12%	48.31%	68.72%
Income Tax Expense	7.04M	11.49M	12.49M	10.22M	5.95M	2.48M	3.93M	4.72M	3.96M	1.57M	1.56M	4.87M	-32.37M	7.43M	5.80M	9.71M	2.44M	0.00	0.00	0.00	768.00K	401.00K	6.77M
Net Income	-55.50M	482.94M	260.34M	119.22M	204.62M	145.61M	137.36M	97.39M	103.97M	-52.67M	58.74M	98.07M	123.09M	84.44M	32.45M	-5.29M	152.21M	0.00	0.00	0.00	64.25M	60.46M	84.18M
Net Income Ratio	-14.27%	131.80%	76.39%	40.39%	71.50%	55.44%	52.43%	37.94%	40.81%	-20.48%	21.80%	36.63%	58.62%	39.06%	15.06%	-2.66%	77.87%	0.00%	0.00%	0.00%	48.51%	51.21%	72.14%
EPS	-1.63	15.09	8.78	4.50	8.37	6.20	6.45	4.60	5.18	-2.93	3.24	5.94	7.57	5.47	2.24	-0.38	12.12	0.00	0.00	0.00	6.60	4.82	6.25
EPS Diluted	-1.63	14.79	8.68	4.09	7.94	6.18	6.06	4.14	4.83	-2.90	3.11	5.89	6.97	5.47	2.24	-0.38	12.12	0.00	0.00	0.00	6.60	4.82	6.25
Weighted Avg Shares Out	34.07M	32.00M	29.66M	26.48M	24.46M	23.47M	21.31M	20.99M	20.07M	17.97M	17.59M	16.51M	15.66M	15.32M	14.44M	13.75M	11.76M	11.72M	11.56M	10.68M	9.14M	11.76M	11.76M
Weighted Avg Shares Out (Dil)	34.07M	32.56M	30.21M	28.55M	26.55M	23.56M	22.73M	21.18M	20.07M	18.13M	18.13M	16.65M	16.70M	15.32M	14.44M	13.75M	11.76M	11.72M	11.56M	10.68M	9.14M	11.76M	11.76M

Cofinimmo SA (CFMOF) Q2 2024 Earnings Call Transcript

July 26, 2024seekingalpha.com

Cofinimmo SA (OTC:CFMOF) Q2 2024 Earnings Conference Call July 26, 2024 5:30 AM ET Company Participants Jean-Pierre Hanin - Chief Executive Officer Sebastien Berden - COO Healthcare; Francoise Roels, Secretary General Yeliz Bicici - COO, Offices & Real Estate Development...